Disclosures The authors Saman Tauqir, Momina Israr, Bushra Rauf, Muhammad Omar Malik, Syed Hamid Habib, Fawad Ali Shah, Muhammad Usman, Muhammad Asif Raza, Inayat Shah, Haroon Badshah, Ehtesham Ehtesham, and Mohsin Shah have nothing to disclose
The FDA warning letter from February 20, 2026 cited misleading marketing language, not an unsafe product, but it is a documented compliance issue patients should factor into their decision
13 Patients whose symptoms are more likely to be of a psychiatric nature are significantly younger, may have a disability, express hypochondria-type behavior, and may have a somatization disorder
The combination should still feel simple: one care team, one intake process, and a plan that matches the client's goals and eligibility
What about heart and kidney protection